Imagene
Founded 2020 · 38 employees on LinkedIn · 1 known investors
Find your way into Imagene
363 people in our graph share verified history with the Imagene team — schools, employers, funds. One of them is your warm intro.
Raz Maysharunlockedknows Dean Bitan · together at Tel Aviv University (overlapped)
×7knows the team · via Tel Aviv University
knows the team · via The Open University of Israel
×2knows the team · via The College of Management Academic Studies
knows the team · via C4I And Cyber Security Directorate, IDF - Israel Defence Forces
Imagene develops AI-based oncology intelligence that turns cancer data into insights to support patient care and drug development. It serves the biotech and clinical oncology market, working with scientists, physicians, and therapy developers.
Founders & leadership
Imagene was founded in 2020 by Dean Bitan, Jonathan Zalach, and Shahar Porat.
DB
Dean BitaninCo-founder · Chief Executive OfficerHe previously founded an AI research and services company and led technology initiatives in molecular testing and precision oncology, including bioinformatics development and automated DNA extraction systems.
JZ
Jonathan ZalachinCDSO & Co-founderCo-founder and Chief Data Science Officer of Imagene, Jonathan Zalach has background in computer vision, machine learning, and deep learning research and technical leadership.
SP
Shahar PoratinCTO & Co-founderShahar Porat is co-founder and CTO of Imagene, which develops AI-based oncology intelligence for cancer diagnosis and personalized therapy using histological data. He has prior experience leading technology companies and projects across various domains.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingMay 2022
Blumberg Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Imagene do?
- Imagene develops AI-based oncology intelligence that turns cancer data into insights to support patient care and drug development. It serves the biotech and clinical oncology market, working with scientists, physicians, and therapy developers.
- Who founded Imagene?
- Imagene was founded by Dean Bitan, Jonathan Zalach, Shahar Porat in 2020.
- Who are Imagene's investors?
- Imagene's investors include Blumberg Capital.